{"id":"W2034585843","doi":"10.1001/jama.290.23.3073","title":"Efalizumab for Patients With Moderate to Severe Plaque Psoriasis","year":2003,"lang":"en","type":"article","venue":"JAMA","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":397,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Placebo; Adverse effect; Severity of illness; Internal medicine; Dermatology; Plaque psoriasis; Randomized controlled trial; Visual analogue scale; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007667108,0.0001794382,0.0002163117,0.00006477591,0.0001764401,0.00002205365,0.0000976247,0.0001868347,0.0002316766],"category_scores_gemma":[0.00007043295,0.0001347197,0.00006586137,0.0001041457,0.00002151917,0.00008540535,0.00001432098,0.0000605313,0.0003581655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004319854,"about_ca_system_score_gemma":0.00004458054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001551563,"about_ca_topic_score_gemma":0.00002089833,"domain_scores_codex":[0.9991326,0.0000903329,0.0001409596,0.0002852345,0.00002924931,0.0003216517],"domain_scores_gemma":[0.9994726,0.000101132,0.00005082238,0.0002248882,0.00011616,0.00003434987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03674488,0.003562096,0.1745169,0.0001627185,0.004382305,0.00003148356,0.004895294,0.0003696054,0.007705823,0.02518145,0.1639924,0.578455],"study_design_scores_gemma":[0.06818766,0.003838307,0.08247609,0.0001161892,0.0006532359,0.00005893979,0.0004302379,0.000005653665,0.1050632,0.00161393,0.7360939,0.001462666],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939707,0.0001888507,0.0006028115,0.0002104012,0.0006259626,0.0006682689,0.0002463991,0.00006048508,0.003426147],"genre_scores_gemma":[0.9928167,0.000009882297,0.001501559,0.0003348441,0.00003613038,0.0002134143,0.0002422981,0.00002616094,0.004818985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5769923,"threshold_uncertainty_score":0.5493709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01132498776174481,"score_gpt":0.2192114849151484,"score_spread":0.2078864971534036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}